FIGO 2023 Upstaging: Overtreatment or Overdue Precision?

Editor's Choice:  FIGO 2023 staging may result in overtreatment of early-stage endometrial cancerEditorial: A path to precision in endometrial cancer management: Moving past FIGO 2023Hosted by: David Gaffney, MD, PhDThe University of Utah, Salt Lake City, Utah, United States of AmericaFeaturing: Allison Roy, MDSUNY Upstate Medical University, Syracuse, NY, United States of AmericaJessica N. McAlpineUniversity of British Columbia,  Vancouver, BC, CanadaDavid MutchWashington University School of Medicine, St Louis, MO, United States of AmericaCheck out more content on the journal's homepage  at https://www.gynecologiconcology-online.net